Status:
COMPLETED
Evaluating the Effects of Kombucha as a Hyperglycemic Therapeutic Agent Within Diabetic Human Subjects
Lead Sponsor:
Georgetown University
Conditions:
Diabetes Mellitus
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This study's primary objective is to determine the ability of Kombucha to impact blood sugar levels in patients with diabetes mellitus type II. The secondary objective is to determine the ability of K...
Eligibility Criteria
Inclusion
- S/he is above the age of 18
- S/he has the ability to read, speak and write English
- S/he has telephone access
- S/he is diabetic and willing to check blood sugar levels every day
- Hb A1c \>7%
- Possesses a glucometer
Exclusion
- Allergy to kombucha ingredients
- Drinks kombucha regularly (\>3time per week)
Key Trial Info
Start Date :
November 11 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2020
Estimated Enrollment :
12 Patients enrolled
Trial Details
Trial ID
NCT04107207
Start Date
November 11 2019
End Date
July 1 2020
Last Update
July 30 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Georgetown University MedStar Hospital
Washington D.C., District of Columbia, United States, 20007